Welcome to our dedicated page for Senseonics SEC filings (Ticker: SENS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Senseonics Holdings, Inc. (SENS) provides access to the company’s official regulatory documents as filed with the U.S. Securities and Exchange Commission. Senseonics is a medical technology company focused on the development and manufacturing of long-term implantable continuous glucose monitoring (CGM) systems, and its filings offer detailed insight into its financial condition, capital structure, and corporate actions.
Among the key documents available are Form 10-K annual reports and Form 10-Q quarterly reports, which describe the company’s business, risk factors, and financial statements related to its Eversense 365 and Eversense E3 glucose monitoring products. Form 8-K current reports disclose material events, such as preliminary financial results, the implementation of a 1-for-20 reverse stock split, special stockholder meetings, and updates on commercialization plans and collaborations.
Investors can also review proxy materials, such as the DEF 14A definitive proxy statement for the special meeting of stockholders that authorized the reverse stock split and proportional reduction in authorized shares. In addition, a Form 25 filing documents the voluntary removal of Senseonics’ common stock from listing and registration on the NYSE American in connection with the transfer of its listing to the Nasdaq Global Select Market.
Through this page, users can follow how Senseonics reports on topics such as revenue updates, capital structure changes, and governance matters. Real-time updates from EDGAR ensure that new filings, including Forms 8-K, 10-Q, and 10-K, appear as they are submitted. AI-powered tools on the platform can help summarize lengthy filings, highlight key sections, and clarify technical language, making it easier to understand how Senseonics’ regulatory disclosures relate to its long-term implantable CGM business.
For those researching SENS, this filings page serves as a central location to review the company’s official SEC documents, track its corporate history, and analyze how its medical technology operations and public company obligations intersect.